Functional MR imaging of the female pelvis

Journal of Magnetic Resonance Imaging

Volumn 25, Issue 6, 2007, Pages 1101-1112

  Koyama, Takashi ^a   Togashi, Kaori ^b,c  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c NONE   (Japan)

Author keywords

Cine MR; Contrast enhanced MR; Diffusion weighted images; Dynamic MR imaging; Female pelvis; Pelvic floor; Uterus

Indexed keywords

CANCER STAGING; CINERADIOGRAPHY; CONTRAST ENHANCEMENT; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; ENDOMETRIOSIS; FEMALE INFERTILITY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GYNECOLOGIC DISEASE; HUMAN; PELVIS; PELVIS FLOOR; PERFUSION; PERISTALSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; SYSTEMATIC REVIEW; TUMOR DIAGNOSIS; UTERUS CONTRACTILITY;

CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENITAL DISEASES, FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; PELVIS; UTERINE CONTRACTION; UTERUS;

EID: 34249914216     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.20913     Document Type: Review

References (101)

1. Lyons EA, Taylor PJ, Zheng XH, Ballard G, Levi CS, Kredentser JV. Characterization of subendometrial myometrial contractions throughout the menstrual cycle in normal fertile women. Fertil Steril 1991;55:771-774.
2. Kunz G, Beil D, Deininger H, Wildt L, Leyendecker G. The dynamics of rapid sperm transport through the female genital tract: evidence from vaginal sonography of uterine peristalsis and hysterosalpingoscintigraphy. Hum Reprod 1996;11:627-632.
3. Togashi K, Kawakami S, Kimura I, et al. Sustained uterine contractions: a cause of hypointense myometrial bulging. Radiology 1993;187:707-710.
4. Togashi K, Kawakami S, Kimura I, et al. Uterine contractions: possible diagnostic pitfall at MR imaging. J Magn Reson Imaging 1993;3:889-893.
5. Masui T, Katayama M, Kobayashi S, et al. Changes in myometrial and junctional zone thickness and signal intensity: demonstration with kinematic T2-weighted MR imaging. Radiology 2001;221:75-85.
6. Masui T, Katayama M, Kobayashi S, Shimizu S, Nozaki A, Sakahara H. Pseudolesions related to uterine contraction: characterization with multiphase-multisection T2-weighted MR imaging. Radiology 2003;227:345-352.
7. Nakai A, Togashi K, Ueda H. Junctional zone on magnetic resonance imaging: continuous changes on ultrafast images. J Women's Imaging 2001;3:89-93.
8. Togashi K, Nakai A, Sugimura K. Anatomy and physiology of the female pelvis: MR imaging revisited. J Magn Reson Imaging 2001; 13:842-849.
9. Nakai A, Togashi K, Yamaoka T, et al. Uterine peristalsis shown on cine MR imaging using ultrafast sequence. J Magn Reson Imaging 2003;18:726-733.
10. Yang A, Mostwin JL, Rosenshein NB, Zerhouni EA, Pelvic floor descent in women: dynamic evaluation with fast MR imaging and cinematic display. Radiology 1991;179:25-33.
11. Fujiwara T, Togashi K, Yamaoka T, et al. Kinematics of the uterus: cine mode MR imaging. Radiographics 2004;24:e19.
12. de Vries K, Lyons EA, Ballard G, Levi CS, Lindsay DJ. Contractions of the inner third of the myometrium. Am J Obstet Gynecol 1990;162:679-682.
13. Nakai A, Togashi K, Kosaka K, et al. Uterine peristalsis: comparison of transvaginal ultrasound and two different sequences of cine MR imaging. J Magn Reson Imaging 2004;20:463-469.
14. Kido A, Togashi K, Nakai A, Ktaoka M, Fujiwara T, Kobayashi A. Circadian rhythm of Uterine peristalsis. In: Proceedings of the 11th Annual Meeting of ISMRM, Toronto, Canada, 2003 (Abstract 464).
15. Bulletti C, de Ziegler D, Polli V, Diotallevi L, Del Ferro E, Flamigni C. Uterine contractility during the menstrual cycle. Hum Reprod 2000;15(Suppl 1):81-89.
16. Chalubinski K, Deutinger J, Bernaschek G. Vaginosonography for recording of cycle-related myometrial contractions. Fertil Steril 1993;59:225-228.
17. Kido A, Nishiura M, Togashi K, et al. A semiautomated technique for evaluation of uterine peristalsis. J Magn Reson Imaging 2005; 21:249-257.
18. Nishiura M, Yuasa M, Watanabe M. Active contour extraction method using partial shape constraint contour model. Systems and computers in Japan 2000;131:20-28.
19. Zondervan KT, Yudkin PL, Vessey MP, et al. Chronic pelvic pain in the community - symptoms, investigations, and diagnoses. Am J Obstet Gynecol 2001;184:1149-1155.
20. Robinson JC, Plichta S, Weisman CS, Nathanson CA, Ensminger M. Dysmenorrhea and use of oral contraceptives in adolescent women attending a family planning clinic. Am J Obstet Gynecol 1992;166:578-583.
21. Andersch B, Milsom I. An epidemiologic study of young women with dysmenorrhea. Am J Obstet Gynecol 1982;144:655-660.
22. Jamieson DJ, Steege JF. The prevalence of dysmenorrhea, dyspareunia, pelvic pain, and irritable bowel syndrome in primary care practices. Obstet Gynecol 1996;87:55-58.
23. Sundell G, Milsom I, Andersch B. Factors influencing the prevalence and severity of dysmenorrhoea in young women. Br J Obstet Gynaecol 1990;97:588-594.
24. Kataoka M, Togashi K, Kido A, et al. Dysmenorrhea: evaluation with cine-mode-display MR imaging - initial experience. Radiology 2005;235:124-131.
25. Stubblefield P. Family planning. In: Berek J, editor. Novak's gynecology. 13th ed. Philadelphia: Lippincott Williams and Wilkins &Wilkins; 2002. p 231-293.
26. Spinnato 2nd JA. Mechanism of action of intrauterine contraceptive devices and its relation to informed consent. Am J Obstet Gynecol 1997;176:503-506.
27. Stanford JB, Mikolajczyk RT. Mechanisms of action of intrauterine devices: update and estimation of postfertilization effects. Am J Obstet Gynecol 2002;187:1699-1708.
28. Lippes J, Malik T, Tatum HJ. The postcoital copper-T. Adv Plan Parent 1976;11:24-29.
29. Kadanali S, Varoglu E, Komec D, Uslu H. Evaluation of active and passive transport mechanisms in genital tracts of IUD-bearing women with radionuclide hysterosalpingoscintigraphy. Contraception 2001;63:41-45.
30. Kido A, Togashi K, Nakai A. Oral contraceptives and uterine peristalsis: evaluation with MRI. In: Proceedings of the 12th Annual Meeting of ISMRM, Kyoto, Japan, 2004 (Abstract 54).
31. Bulletti C, De Ziegler D, Polli V, Flamigni C. The role of leiomyomas in infertility. J Am Assoc Gynecol Laparosc 1999;6:441-445.
32. Bajekal N, Li TC. Fibroids, infertility and pregnancy wastage. Hum Reprod Update 2000;6:614-620.
33. Donnez J, Jadoul P. What are the implications of myomas on fertility? A need for a debate? Hum Reprod 2002;17:1424-1430.
34. Nishino M, Togashi K, Nakai A, et al. Uterine contractions evaluated on cine MR imaging in patients with uterine leiomyomas. Eur J Radiol 2005;53:142-146.
35. Somigliana E, Vigano P, Rossi G, Carinelli S, Vignali M, Panina-Bordignon P. Endometrial ability to implant in ectopic sites can be prevented by interleukin-12 in a murine model of endometriosis. Hum Reprod 1999;14:2944-2950.
36. Schenken RS, Guzick DS. Revised endometriosis classification: 1996. Fertil Steril 1997;67:815-816.
37. Kido A, Togashi K, Nishino M, et al. Uterine peristalsis on cine MR imaging in patients with endometriosis. Eur Radiol 2006 Nov 22 [Epub ahead of print].
38. Fielding JR. Practical MR imaging of female pelvic floor weakness. Radiographics 2002;22:295-304.
39. Le Bihan D, Breton E, Lallemand D, Grenier P, Cabanis E, Laval-Jeantet M. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 1986;161:401-407.
40. Le Bihan D. Intravoxel incoherent motion imaging using steadystate free precession. Magn Reson Med 1988;7:346-351.
41. Bahn MM, Oser AB. Cross 3rd DT, CT and MRI of stroke. J Magn Reson Imaging 1996;6:833-845.
42. Li TQ, Takahashi AM, Hindmarsh T, Moseley ME. ADC mapping by means of a single-shot spiral MRI technique with application in acute cerebral ischemia. Magn Reson Med 1999;41:143-147.
43. Tien RD, Felsberg GJ, Friedman H, Brown M, MacFall J. MR imaging of high-grade cerebral gliomas: value of diffusion-weighted echoplanar pulse sequences. AJR Am J Roentgenol 1994;162:671-677.
44. Le Bihan D, Turner R, Douek P, Patronas N. Diffusion MR imaging: clinical applications. AJR Am J Roentgenol 1992;159:591-599.
45. Kurihara Y, Yakushiji YK, Tani I, Nakajima Y, Van Cauteren M. Coil sensitivity encoding in MR imaging: advantages and disadvantages in clinical practice. AJR Am J Roentgenol 2002;178: 1087-1091.
46. Bammer R, Keeling SL, Augustin M, et al. Improved diffusion-weighted single-shot echo-planar imaging (EPI) in stroke using sensitivity encoding (SENSE). Magn Reson Med 2001;46:548-554.
47. Muller MF, Prasad P, Siewert B, Nissenbaum MA, Raptopoulos V, Edelman RR. Abdominal diffusion mapping with use of a whole-body echo-planar system. Radiology 1994;190:475-478.
48. Murtz P, Flacke S, Traber F, van den Brink JS, Gieseke J, Schild HH. Abdomen: diffusion-weighted MR imaging with pulse-triggered single-shot sequences. Radiology 2002;224:258-264.
49. Nasu K, Kuroki Y, Kuroki S, Murakami K, Nawano S, Moriyama N. Diffusion-weighted single shot echo planar imaging of colorectal cancer using a sensitivity-encoding technique. Jpn J Clin Oncol 2004;34:620-626.
50. Ichikawa T, Haradome H, Hachiya J, Nitatori T, Araki T. Diffusion-weighted MR imaging with a single-shot echoplanar sequence: detection and characterization of focal hepatic lesions. AJR Am J Roentgenol 1998;170:397-402.
51. Nasu K, Kuroki Y, Nawano S, et al. Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging. Radiology 2006;239:122-130.
52. Takahara T, Imai Y, Yamashita T, Yasuda S, Nasu S, Van Cauteren M. Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med 2004;22:275-282.
53. Yamada I, Aung W, Himeno Y, Nakagawa T, Shibuya H. Diffusion coefficients in abdominal organs and hepatic lesions: evaluation with intravoxel incoherent motion echo-planar MR imaging. Radiology 1999;210:617-623.
54. Turner R, Le Bihan D, Maier J, Vavrek R, Hedges LK, Pekar J. Echo-planar imaging of intravoxel incoherent motion. Radiology 1990;177:407-414.
55. Edelman RR, Wielopolski P, Schmitt F. Echo-planar MR imaging. Radiology 1994;192:600-612.
56. Provenzale JM, Engelter ST, Petrella JR, Smith JS, MacFall JR. Use of MR exponential diffusion-weighted images to eradicate T2 "shine-through" effect. AJR Am J Roentgenol 1999;172:537-539.
57. Koyama T, Umeoka S, Kataoka M, et al. Utility of diffusion-weighted MR imaging in evaluation of esophageal cancers. In: Proceedings of the 13th Annual Meeting of ISMRM, Miami Beach, FL, USA (Abstract 2820).
58. Koyama T, Tamai K, Umeoka S, Saga T, Fujii S, Togashi K. Value of Diffusion-weighted images in Ovarian tumors. In: Proceedings of the 14th Annual Meeting of ISMRM, Seattle, WA, USA (Abstract 305).
59. Umeoka S, Koyama T, Saga T, et al. Ectopically located gonads in a patient with mixed gonadal dysgenesis: detection by diffusion-weighted MRI. Abdom Imaging 2005;30:637-640.
60. Castillo M, Arbelaez A, Smith JK, Fisher LL. Diffusion-weighted MR imaging offers no advantage over routine noncontrast MR imaging in the detection of vertebral metastases. AJNR Am J Neuroradiol 2000;21:948-953.
61. Koyama T, Tamai K, Togashi K. Current status of body MR imaging; fast MR imaging and diffusion-weighted imaging. Int J Clin Oncol 2006;11:278-285.
62. Provenzale JM, Mukundan S, Barboriak DP. Diffusion-weighted and perfusion MR imaging for brain tumor characterization and assessment of treatment response. Radiology 2006;239:632-649.
63. Castillo M, Smith JK, Kwock L, Wilber K. Apparent diffusion coefficients in the evaluation of high-grade cerebral gliomas. AJNR Am J Neuroradiol 2001;22:60-64.
64. Lyng H, Haraldseth O, Rofstad EK. Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging. Magn Reson Med 2000;43: 828-836.
65. Szafer A, Zhong J, Gore JC. Theoretical model for water diffusion in tissues. Magn Reson Med 1995;33:697-712.
66. Uhl M, Altehoefer C, Kontny U, Il'yasov K, Buchert M, Langer M. MRI-diffusion imaging of neuroblastomas: first results and correlation to histology. Eur Radiol 2002;12:2335-2338.
67. Nonomura Y, Yasumoto M, Yoshimura R, et al. Relationship between bone marrow cellularity and apparent diffusion coefficient. J Magn Reson Imaging 2001;13:757-760.
68. Tamai K, Koyama T, Saga T, et al. Diffusion-weighted MR imaging of uterine endometrial cancer. In: Proceedings of the 14th Annual Meeting of ISMRM, Seattle, WA, USA (Abstract 3450).
69. Naganawa S, Sato C, Kumada H, Ishigaki T, Miura S, Takizawa O. Apparent diffusion coefficient in cervical cancer of the uterus: comparison with the normal uterine cervix. Eur Radiol 2005;15: 71-78.
70. Liapi E, Kamel IR, Bluemke DA, Jacobs MA, Kim HS. Assessment of response of uterine fibroids and myometrium to embolization using diffusion-weighted echoplanar MR imaging. J Comput Assist Tomogr 2005;29:83-86.
71. Jacobs MA, Herskovits EH, Kim HS. Uterine fibroids: diffusion-weighted MR imaging for monitoring therapy with focused ultrasound surgery - preliminary study. Radiology 2005;236:196-203.
72. Moteki T, Ishizaka H. Diffusion-weighted EPI of cystic ovarian lesions: evaluation of cystic contents using apparent diffusion coefficients. J Magn Reson Imaging 2000;12:1014-1019.
73. Nakayama T, Yoshimitsu K, Irie H, et al. Diffusion-weighted echoplanar MR imaging and ADC mapping in the differential diagnosis of ovarian cystic masses: usefulness of detecting keratinoid substances in mature cystic teratomas. J Magn Reson Imaging 2005; 22:271-278.
74. Katayama M, Masui T, Kobayashi S, et al. Diffusion-weighted echo planar imaging of ovarian tumors: is it useful to measure apparent diffusion coefficients? J Comput Assist Tomogr 2002;26:250-256.
75. Yang JC, Haworth L, Sherry RM, et al. A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. N Engl J Med 2003;349:427-434.
76. Morgan B, Thomas AL, Drevs J, et al. Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer and liver metastases: results from two phase 1 studies. J Clin Oncol 2003;21:3955-3964.
77. Hawighorst H, Knapstein PG, Weikel W. et al. Cervical carcinoma: comparison of standard and pharmacokinetic MR imaging. Radiology 1996;201:531-539.
78. Padhani AR. MRI for assessing antivascular cancer treatments. Br J Radiol 2003;76(Spec No 1):S60-S80.
79. Padhani AR, Leach MO. Antivascular cancer treatments: functional assessments by dynamic contrast-enhanced magnetic resonance imaging. Abdom Imaging 2005;30:324-341.
80. Carlson J, Crooks L, Ortendahl D, Kramer DM, Kaufman L. Signal-to-noise ratio and section thickness in two-dimensional versus three-dimensional Fourier transform MR imaging. Radiology 1988;166(1 Pt 1):266-270.
81. Rofsky NM, Lee VS, Laub G, et al. Abdominal MR imaging with a volumetric interpolated breath-hold examination. Radiology 1999;212:876-884.
82. Yamashita Y, Harada M, Sawada T, Takahashi M, Miyazaki K, Okamura H. Normal uterus and FIGO stage I endometrial carcinoma: dynamic gadolinium-enhanced MR imaging. Radiology 1993;186:495-501.
83. Ito K, Matsumoto T, Nakada T, Nakanishi T, Fujita N, Yamashita H. Assessing myometrial invasion by endometrial carcinoma with dynamic MRI. J Comput Assist Tomogr 1994;18:77-86.
84. Seki H, Kimura M, Sakai K. Myometrial invasion of endometrial carcinoma: assessment with dynamic MR and contrast-enhanced T1-weighted images. Clin Radiol 1997;52:18-23.
85. Joja I, Asakawa M, Asakawa T, et al. Endometrial carcinoma: dynamic MRI with turbo-FLASH technique. J Comput Assist Tomogr 1996;20:878-887.
86. Takahashi S, Murakami T, Narumi Y, et al. Preoperative staging of endometrial carcinoma: diagnostic effect of T2-weighted fast spin-echo MR imaging. Radiology 1998;206:539-547.
87. Yamashita Y, Takahashi M, Sawada T, Miyazaki K, Okamura H. Carcinoma of the cervix: dynamic MR imaging. Radiology 1992; 182:643-648.
88. Tsuda K, Murakami T, Kurachi H, et al. MR imaging of cervical carcinoma: comparison among T2-weighted, dynamic, and post-contrast T1-weighted images with histopathological correlation. Abdom Imaging 1997;22:103-107.
89. Hawnaur JM, Zhu XP, Hutchinson CE. Quantitative dynamic contrast enhanced MRI of recurrent pelvic masses in patients treated for cancer. Br J Radiol 1998;71:1136-1142.
90. Kinkel K, Ariche M, Tardivon AA, et al. Differentiation between recurrent tumor and benign conditions after treatment of gynecologic pelvic carcinoma: value of dynamic contrast-enhanced subtraction MR imaging. Radiology 1997;204:55-63.
91. Mayr NA, Yuh WT, Magnotta VA, et al. Tumor perfusion studies using fast magnetic resonance imaging technique in advanced cervical cancer: a new noninvasive predictive assay. Int J Radiat Oncol Biol Phys 1996;36:623-633.
92. Padhani AR. Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions. J Magn Reson Imaging 2002;16:407-422.
93. Boss EA, Massuger LF, Pop LA, et al. Post-radiotherapy contrast enhancement changes in fast dynamic MRI of cervical carcinoma. J Magn Reson Imaging 2001;13:600-606.
94. Shimada K, Ohashi I, Kasahara I, Miyasaka N, Shibuya H. Triple-phase dynamic MRI of intratumoral vessel density and hyalinization grade in uterine leiomyomas. AJR Am J Roentgenol 2004; 182:1043-1050.
95. Li W, Brophy DP, Chen Q, Edelman RR, Prasad PV. Semiquantitative assessment of uterine perfusion using first pass dynamic contrast-enhanced MR imaging for patients treated with uterine fibroid embolization. J Magn Reson Imaging 2000;12:1004-1008.
96. Yamashita Y, Torashima M, Takahashi M, et al. Hyperintense uterine leiomyoma at T2-weighted MR imaging: differentiation with dynamic enhanced MR imaging and clinical implications. Radiology 1993;189:721-725.
97. Parker GJ, Suckling J, Tanner SF, et al. Probing tumor microvascularity by measurement, analysis and display of contrast agent uptake kinetics. J Magn Reson Imaging 1997;7:564-574.
98. Tofts PS. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 1997;7:91-101.
99. Hawighorst H, Weikel W, Knapstein PG, et al. Angiogenic activity of cervical carcinoma: assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome. Clin Cancer Res 1998;4:2305-2312.
100. Hawighorst H, Knapstein PG, Knopp MV, et al. Uterine cervical carcinoma: comparison of standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival. Cancer Res 1998;58:3598-3602.
101. Yamashita Y, Baba T, Baba Y, et al. Dynamic contrast-enhanced MR imaging of uterine cervical cancer: pharmacokinetic analysis with histopathologic correlation and its importance in predicting the outcome of radiation therapy. Radiology 2000;216:803-809.